Cogent Biosciences (COGT) Other Non Operating Income (2017 - 2026)
Cogent Biosciences' (COGT) quarterly Other Non Operating Income came in at -$140000.0 in Q1 2026, down 2700.0% year-on-year from $5384.6 in Q1 2025, and down 2233.33% on a QoQ basis from -$6000.0 in Q4 2025.
Cogent Biosciences (COGT) Other Non Operating Income (2017 - 2026) Analysis & Trends
Cogent Biosciences (COGT) has 10 years of Other Non Operating Income data on file, last reported at -$140000.0 in Q1 2026.
- On a quarterly basis, Other Non Operating Income fell 2700.0% year-over-year to -$140000.0 in Q1 2026; TTM through Mar 2026 was -$155000.0, a 107.8% decrease from a year earlier, with the FY2025 full-year figure at -$20000.0, down 101.0% from the prior year.
- Other Non Operating Income for Q1 2026 stood at -$140000.0, down from -$6000.0 in the prior quarter.
- Over the last five years, Other Non Operating Income for COGT reached as high as $1.9 million in Q4 2024 and fell as low as -$140000.0 in Q1 2026.
- Historically, Other Non Operating Income has averaged $314000.0 across 5 years, with a median of $22500.0 in 2024.
- Across the five-year window, Other Non Operating Income jumped 27928.57% in 2024 and slumped 2700.0% in 2026, its largest moves.
- Year by year, Other Non Operating Income stood at $657000.0 in 2022, then sank by 101.07% to -$7000.0 in 2023, then soared by 27928.57% to $1.9 million in 2024, then slumped by 100.31% to -$6000.0 in 2025, then sank by 2233.33% to -$140000.0 in 2026.
- Per Business Quant data, the three most recent Other Non Operating Income figures were -$140000.0 in Q1 2026, -$6000.0 in Q4 2025, and -$3000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Cogent Biosciences | 6.45 Bn | 6.45 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -140,000.00 |
| Dec 31, 2025 | -6,000.00 |
| Sep 30, 2025 | -3,000.00 |
| Jun 30, 2025 | -6,000.00 |
| Mar 31, 2025 | -5,000.00 |
| Dec 31, 2024 | 1.95 Mn |
| Sep 30, 2024 | 1,000.00 |
| Jun 30, 2024 | 44,000.00 |
| Mar 31, 2024 | -1,000.00 |
| Dec 31, 2023 | -7,000.00 |
| Jun 30, 2023 | 268,000.00 |
| Mar 31, 2023 | 682,000.00 |
| Dec 31, 2022 | 657,000.00 |
| Sep 30, 2022 | 259,000.00 |
| Jun 30, 2022 | 656,000.00 |
| Mar 31, 2022 | 677,000.00 |
| Dec 31, 2021 | 621,000.00 |
| Sep 30, 2021 | 620,000.00 |
| Jun 30, 2021 | 623,000.00 |
| Mar 31, 2021 | 604,000.00 |